Neoadjuvant and Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Neoadjuvant and Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Authors: Lin Yuxuan, Xia Yong, Shen Feng Source: Chinese Journal of Hepatobiliary Surgery, 2023, 29(7) Abstract Intrahepatic cholangiocarcinoma (ICC) is a type of adenocarcinoma originating from the intrahepatic secondary bile ducts and their branches, characterized by high malignancy and poor prognosis. Radical surgical resection is currently the only potentially curative treatment for ICC, but only … Read more

Efficacy of the Novel PD-L1 Inhibitor Socazolimab in Neoadjuvant Treatment Combined with Chemotherapy for Locally Advanced ESCC Requires Phase III Trial Validation

Efficacy of the Novel PD-L1 Inhibitor Socazolimab in Neoadjuvant Treatment Combined with Chemotherapy for Locally Advanced ESCC Requires Phase III Trial Validation

Click the blue text above“ioncologyGI” to follow us, then click the “…” menu in the upper right corner and select “Set as Favorite”Neoadjuvant concurrent chemoradiotherapy remains the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). Recent studies have also shown survival advantages from neoadjuvant chemotherapy alone, but the improvement in pathological complete response … Read more

Establishment and Application of Preoperative Scoring System for Resectable Pancreatic Cancer

Establishment and Application of Preoperative Scoring System for Resectable Pancreatic Cancer

Pancreatic cancer is a highly malignant and lethal tumor, with a high incidence and extremely poor prognosis. According to the 2021 cancer data from the United States, the incidence of pancreatic cancer continues to rise, ranking 10th among new cases in men and 9th in women, with a mortality rate that ranks 4th among all … Read more

Professor Wang Shu: Long-term Follow-up and Meta-analysis of Adjuvant Endocrine Therapy for Premenopausal HR+ Early Breast Cancer Patients with OFS+AI

Professor Wang Shu: Long-term Follow-up and Meta-analysis of Adjuvant Endocrine Therapy for Premenopausal HR+ Early Breast Cancer Patients with OFS+AI

Click the blue text to follow us! From December 7 to 10, 2021, the 44th San Antonio Breast Cancer Symposium (SABCS) was grandly held. At this conference, updated follow-up data from the TEXT and SOFT studies over 13 years [1] were presented, along with the results of four randomized controlled trials (ABCSG 12, TEXT, SOFT, … Read more